The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Revealing the cellular degradome by mass spectrometry analysis of proteasome-cleaved peptides
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These and other longer RNAs might be the direct result of the cell degradome, known mostly for proteins (52,53) but which has been shown to be also existent for RNAs (54,55).”
From miRNATissueAtlas2: an update to the human miRNA tissue atlas (2022) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
Mass-spectrometric exploration of proteome structure and function
Aebersold, R., & Mann, M. (2016) · Nature · doi:10.1038/nature19949 · Cited by 2,334
How many human proteoforms are there?
Aebersold, R., Agar, J. N., Amster, I. J., Baker, M. S., Bertozzi, C. R., Boja, E. S., Costello, C. E., Cravatt, B. F., Fenselau, C., Garcia, B. A., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2576 · Cited by 907
Geiger, T., Wehner, A., Schaab, C., Cox, J., & Mann, M. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014050 · Cited by 797
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
McKinney, E. F., Lee, J. C., Jayne, D. R. W., Lyons, P. A., & Smith, K. G. C. (2015) · Nature · doi:10.1038/nature14468 · Cited by 685
Oxidative stress in the pathology and treatment of systemic lupus erythematosus
Perl, A. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.147 · Cited by 358
Turnover of the Human Proteome: Determination of Protein Intracellular Stability by Dynamic SILAC
Doherty, M. K., Hammond, D. E., Clague, M. J., Gaskell, S. J., & Beynon, R. J. (2009) · Journal of Proteome Research · doi:10.1021/pr800641v · Cited by 340
Analysis of High Accuracy, Quantitative Proteomics Data in the MaxQB Database
Schaab, C., Geiger, T., Stoehr, G., Cox, J., & Mann, M. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014068 · Cited by 164
Research works printed but not linked: 40
- Rock, K.L. et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761–771 (1994). · DOI · Paper page
- Schmidt, M. & Finley, D. Regulation of proteasome activity in health and disease. Biochim. Biophys. Acta 1843, 13–25 (2014). · DOI
- Hershko, A. & Ciechanover, A. The ubiquitin system for protein degradation. Annu. Rev. Biochem. 61, 761–807 (1992). · DOI
- Finley, D., Chen, X. & Walters, K.J. Gates, channels, and switches: elements of the proteasome machine. Trends Biochem. Sci. 41, 77–93 (2016). · DOI
- Rock, K.L., York, I.A., Saric, T. & Goldberg, A.L. Protein degradation and the generation of MHC class I-presented peptides. Adv. Immunol. 80, 1–70 (2002). · DOI
- Rock, K.L., Reits, E. & Neefjes, J. Present yourself! By MHC class I and MHC class II molecules. Trends Immunol. 37, 724–737 (2016). · DOI · Paper page
- Rape, M. & Jentsch, S. Taking a bite: proteasomal protein processing. Nat. Cell Biol. 4, E113–E116 (2002). · DOI
- Yen, H.-C.S., Xu, Q., Chou, D.M., Zhao, Z. & Elledge, S. J. Global protein stability profiling in mammalian cells. Science 322, 918–923 (2008). · DOI · Paper page
- Savitski, M.M. et al. Multiplexed proteome dynamics profiling reveals mechanisms controlling protein homeostasis. Cell 173, 260–274.e25 (2018). · DOI
- Kim, W. et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 44, 325–340 (2011). · DOI
- Mathieson, T. et al. Systematic analysis of protein turnover in primary cells. Nat. Commun. 9, 689 (2018). · DOI
- McShane, E. et al. Kinetic analysis of protein stability reveals age-dependent degradation. Cell 167, 803–815.e21 (2016). · DOI
- Eden, E. et al. Proteome half-life dynamics in living human cells. Science 331, 764–768 (2011). · DOI
- Mann, M. & Kelleher, N.L. Precision proteomics: the case for high resolution and high mass accuracy. Proc. Natl. Acad. Sci. USA 105, 18132–18138 (2008). · DOI · Paper page
- Larance, M., Ahmad, Y., Kirkwood, K.J., Ly, T. & Lamond, A.I. Global subcellular characterization of protein degradation using quantitative proteomics. Mol. Cell. Proteomics 12, 638–650 (2013). · DOI
- Cardozo, C., Vinitsky, A., Hidalgo, M.C., Michaud, C. & Orlowski, M. A 3,4-dichloroisocoumarin-resistant component of the multicatalytic proteinase complex. Biochemistry 31, 7373–7380 (1992). · DOI
- Nussbaum, A.K. et al. Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1. Proc. Natl. Acad. Sci. USA 95, 12504–12509 (1998). · DOI
- Zhou, F. et al. Genome-scale proteome quantification by DEEP SEQ mass spectrometry. Nat. Commun. 4, 2171 (2013). · DOI
- Feist, E., Burmester, G.-R. & Krüger, E. The proteasome: victim or culprit in autoimmunity. Clin. Immunol. 172, 83–89 (2016). · DOI
- Ullrich, O. et al. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc. Natl. Acad. Sci. USA 96, 6223–6228 (1999). · DOI
- Cervantes-Laurean, D., Roberts, M.J., Jacobson, E.L. & Jacobson, M.K. Nuclear proteasome activation and degradation of carboxymethylated histones in human keratinocytes following glyoxal treatment. Free Radic. Biol. Med. 38, 786–795 (2005). · DOI
- Wang, C.H., Wu, S.B., Wu, Y.T. & Wei, Y.H. Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging. Exp. Biol. Med. (Maywood) 238, 450–460 (2013). · DOI
- Cadenas, E. & Davies, K.J. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 29, 222–230 (2000). · DOI · Paper page
- Kisselev, A.F., Kaganovich, D. & Goldberg, A.L. Binding of hydrophobic peptides to several non-catalytic sites promotes peptide hydrolysis by all active sites of 20 S proteasomes: evidence for peptide-induced channel opening in the alpha-rings. J. Biol. Chem. 277, 22260–22270 (2002). · DOI
- Schmidtke, G., Emch, S., Groettrup, M. & Holzhütter, H.-G. Evidence for the existence of a non-catalytic modifier site of peptide hydrolysis by the 20 S proteasome. J. Biol. Chem. 275, 22056–22063 (2000). · DOI
- Liepe, J. et al. Quantitative time-resolved analysis reveals intricate, differential regulation of standard- and immuno-proteasomes. eLife 4, e07545 (2015). · DOI
- Murakami, Y. et al. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360, 597–599 (1992). · DOI
- Vlashi, E. et al. In vivo imaging, tracking, and targeting of cancer stem cells. J. Natl. Cancer Inst. 101, 350–359 (2009). · DOI
- Philips, G.K. & Atkins, M. Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies. Int. Immunol. 27, 39–46 (2015). · DOI
- Yang, W., Chen, P.W., Li, H., Alizadeh, H. & Niederkorn, J.Y. PD-L1: PD-1 interaction contributes to the functional suppression of T-cell responses to human uveal melanoma cells in vitro. Invest. Opthalmol. Vis. Sci. 49, 2518–2525 (2008). · DOI
- Tan, E.M. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25, 1271–1277 (1982). · DOI · Paper page
- Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008). · DOI · Paper page
- Bassani-Sternberg, M., Pletscher-Frankild, S., Jensen, L.J. & Mann, M. Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation. Mol. Cell. Proteomics 14, 658–673 (2015). · DOI
- Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731–740 (2016). · DOI · Paper page
- Mi, H. et al. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res. 33, D284–D288 (2005). · DOI
- Ruepp, A. et al. CORUM: the comprehensive resource of mammalian protein complexes. Nucleic Acids Res. 36, D646–D650 (2008). · DOI
- Ruepp, A. et al. CORUM: the comprehensive resource of mammalian protein complexes--2009. Nucleic Acids Res. 38, D497–D501 (2010). · DOI
- Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003). · DOI · Paper page
- You, Y., Jang, I., Lee, K., Kim, H. & Lee, K. An approach for a substitution matrix based on protein blocks and physicochemical properties of amino acids through PCA. Interdiscip. Bio Cent. 6, 3.1–3.10 (2014). · DOI
- Vizca&no, J.A. et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 44, D447–D456 (2016). · DOI
Cited by
Sorted by citations
miRNATissueAtlas2: an update to the human miRNA tissue atlas
Keller, A., Gröger, L., Tschernig, T., Solomon, J., Laham, O., Schaum, N., Wagner, V., Kern, F., Schmartz, G. P., Li, Y., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab808 · Cited by 143
Metadata
- Authors
- Wolf-Levy, H., Javitt, A., Eisenberg-Lerner, A., Kacen, A., Ulman, A., Sheban, D., Dassa, B., Fishbain-Yoskovitz, V., Carmona-Rivera, C., Kramer, M. P., Nudel, N., Regev, I., Zahavi, L., Elinger, D., Kaplan, M. J., Morgenstern, D., Levin, Y., & Merbl, Y.
- Venue
- Nature Biotechnology
- Published
- 2018-10-22
- Volume
- 36
- Issue
- 11
- Pages
- 1110-1116
- ISSN
- 1087-0156
- 1546-1696
- PMC
- PMC8897557
- Cited by
- 55
- References
- 9
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review